For open systems
PRODUCTFor open systems
For open systems
Applicable on all open biochemistry analyzers Good stability and long shelf life to 12-24months Cost-effective
Details
Clinical chemistry reagents for Hitachi, Olympus etc.
Features:
Ready-to-use liquid reagents
Applicable on all open biochemistry analyzers
Good stability and long shelf life to 12-24months
Cost-effective
The test items includes,
ApoA1, ApoB, CHOL, CK, CKMB, HDLC, LD, LD1,LPS,Lp(a), LDLC, TG,HBDH
CA, MG,PHOS
ALT, ALB, ALP, AST, DBIL, TBA, TBIL, TP, AFU, GGT
GLU, AMY
CREA, UREA, UA
Clinical chemistry reagents for Hitachi, Olympus etc. | ||||
CARDIOVASCULAR DISEASE | ||||
Cat# | Abbreviation | Method | Form | Size |
L-201201 | ApoA1 | Immunoturbidimetric | Dual Liquid-stable | R-1: 60ml×2, R-2: 20ml×2 |
L-201301 | ApoB | Immunoturbidimetric | Dual Liquid-stable | R-1: 60ml×2, R-2: 20ml×2 |
L-200101 | CHOL | Enzymatic | Dual Liquid-stable | R-1: 60ml×2, R-2: 20ml×2 |
L-201901 | CK | NAC | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
L-202001 | CKMB | NAC-Immunoinhibition | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
L-200201 | HDLC | Direct | Dual Liquid-stable | R-1: 60ml×2, R-2: 20ml×2 |
L-202401 | LD | Lactate to Pyruvate | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
L-202501 | LD1 | NAC-Immunoinhibition | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
L-200501 | [Lpa] | Immunoturbidimetric | Dual Liquid-stable | R-1: 60ml×2, R-2: 20ml×2 |
L-200801 | LDLC | Direct | Dual Liquid-stable | R-1: 60ml×2, R-2: 20ml×2 |
L-200601 | TG | Enzymatic/GPO Trinder, Endpoint | Dual Liquid-stable | R-1: 60ml×2, R-2: 20ml×2 |
L-000702 | HBDH | DGKC | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
ELECTROLYTE | ||||
Cat# | Abbreviation | Method | Form | Size |
L-000102 | CA | Arsenazo Ⅲ | Mono Liquid-stable | R: 60ml×2 |
L-000202 | MG | Calmagite Colorimetric | Dual Liquid-stable | R: 60ml×2 |
L-200401 | PHOS | Ultra Violet | Dual Liquid-stable | R-1: 60ml×2, R-2: 20ml×2 |
LIVER DISEASE | ||||
Cat# | Abbreviation | Method | Form | Size |
L-201801 | ALT | IFCC | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
L-000802 | ALB | Bromcresol Green Colorimetric | Mono Liquid-stable | R: 60ml×2 |
L-200301 | ALB | Bromcresol Purple Colorimetric | Mono Liquid-stable | R: 70ml×2 |
L-202101 | ALP | AMP | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
L-202601 | AST | IFCC | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
L-000502 | DBIL | Vanadate Oxidation | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
L-202701 | TBA | Enzyme Cycling Method | Dual Liquid-stable | R-1: 60ml×2, R-2: 20ml×2 |
L-000402 | TBIL | Vanadate Oxidation | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
L-200701 | TP | Biuret | Mono Liquid-stable | R: 70ml×2 |
L-201501 | AFU | CNPF | Mono Liquid-stable | R: 60ml×2 |
L-201701 | GGT | Rate | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
METABOLIC DISEASE | ||||
Cat# | Abbreviation | Method | Form | Size |
L-000302 | GLU | Oxidase | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
L-200901 | GLU | Hexokinase | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
PANCREATIC DISEASE | ||||
Cat# | Abbreviation | Method | Form | Size |
L-000602 | AMY | CNPG3 | Mono Liquid-stable | R: 60ml×2 |
L-201601 | AMY | EPS-G7 | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
RENAL DISEASE | ||||
Cat# | Abbreviation | Method | Form | Size |
L-201001 | CREA | Sarcosine Oxidase | Dual Liquid-stable | R-1: 60ml×2, R-2: 20ml×2 |
L-201104 | CREA | Picric Acid | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
L-202201 | UREA | Urease/Glutamate Dehydrogenase | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |
L-202301 | UA | Uricase | Dual Liquid-stable | R-1: 60ml×2, R-2: 15ml×2 |